The Punjab health minister has announced that the Drug Act, 1976, will be amended to enable the provincial governments to proceed against the makers and sellers of spurious non-allopathic (unani, ayurvedic and homoeopathic) drugs. This is a welcome move. Given that more and more people are now turning to alternative medicine, it is important that some checks be employed on this sector which has so far been hardly regulated.
The absence of registration of the practitioners of the various branches of medicine and the failure to exercise any control over them has enabled a large number of quacks to come up and play havoc with the lives and health of the people. Hence this should be a good beginning in the field. But it needs to be pointed out that the allopathic drugs which are still the more commonly used ones and which come under the purview of the 1976 drug act are faring no better.
In their case it is not the lack of a legal framework that prevents the government from taking action against the manufacturers and sellers of spurious drugs. It is the failure to implement the law and the absence of an effective and efficient mechanism to monitor the drugs which are commonly on sale.
The fact is that the health ministry which is responsible for ensuring that drug inspectors are appointed in the provinces to keep an eye on the pharmaceutical market is not doing its job. The inspectors are either not there or if they have been appointed they are turning a blind eye to the spurious and counterfeit drugs with which the market is flooded. If it were not so, how is it that the WHO has found 50 per cent of the drugs available in the market to be spurious? Moreover, if effective control was there, it is unlikely that the chemists and pharmacists would have been openly selling two qualities of the same brand after inquiring from the customer if he wanted the one or the other quality.
It is this aspect of the problem that needs immediate attention. Undeniably, the health ministry has proved unable to play this regulatory role. A better option at this stage would therefore be to set up an autonomous drug control authority not under the health ministry but comprising independent professionals and persons of high public standing and integrity. That body should be patterned on the Federal Drug Administration of America. Such an agency will doubtless be better placed to act effectively and check the menace of spurious and sub-standard drugs.